scholarly article | Q13442814 |
P2093 | author name string | H Shen | |
A J Marcus | |||
R Kraemer | |||
R K Upmacis | |||
J H F Drosopoulos | |||
E Musi | |||
P2860 | cites work | Platelet degranulation is associated with progression of intima-media thickness of the common carotid artery in patients with diabetes mellitus type 2. | Q52939233 |
Platelet, Not Endothelial, P-Selectin Is Required for Neointimal Formation After Vascular Injury | Q56944225 | ||
CD73/Ecto-5′-Nucleotidase Protects Against Vascular Inflammation and Neointima Formation | Q61612314 | ||
Targeting platelet aggregation: CD39 gene transfer augments nucleoside triphosphate diphosphohydrolase activity in injured rabbit arteries | Q64379610 | ||
Recombinant adenoviral mediated CD39 gene transfer prolongs cardiac xenograft survival | Q64380399 | ||
Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury | Q72097139 | ||
Analysis of CD39/ATP diphosphohydrolase (ATPDase) expression in endothelial cells, platelets and leukocytes | Q73267219 | ||
Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils | Q73435130 | ||
Site-directed mutagenesis of human endothelial cell ecto-ADPase/soluble CD39: requirement of glutamate 174 and serine 218 for enzyme activity and inhibition of platelet recruitment | Q73861917 | ||
Beta(3)-integrin-deficient mice but not P-selectin-deficient mice develop intimal hyperplasia after vascular injury: correlation with leukocyte recruitment to adherent platelets 1 hour after injury | Q73919572 | ||
Structural elements and limited proteolysis of CD39 influence ATP diphosphohydrolase activity | Q74462843 | ||
The transmembrane domains of ectoapyrase (CD39) affect its enzymatic activity and quaternary structure | Q77229195 | ||
Constraints imposed by transmembrane domains affect enzymatic activity of membrane-associated human CD39/NTPDase1 mutants | Q79995310 | ||
P2 receptors in atherosclerosis and postangioplasty restenosis | Q81060318 | ||
The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization | Q24323556 | ||
Identification and characterization of CD39/vascular ATP diphosphohydrolase | Q24336540 | ||
Heterologous cell-cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1) | Q28166484 | ||
Effects of SolCD39, a novel inhibitor of Platelet Aggregation, on Platelet Deposition and Aggregation after PTCA in a Porcine Model | Q28185689 | ||
Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain | Q28192804 | ||
Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation | Q28594120 | ||
Arterial injury increases expression of inflammatory adhesion molecules in the carotid arteries of apolipoprotein-E-deficient mice | Q30304455 | ||
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance | Q30436506 | ||
The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. | Q30448825 | ||
Expression of intercellular adhesion molecule-1 in human coronary endothelial and smooth muscle cells after stimulation with tumor necrosis factor-alpha | Q31919799 | ||
Real-time imaging of mechanically injured femoral artery in mice reveals a biphasic pattern of leukocyte accumulation | Q33266721 | ||
Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia | Q33342172 | ||
Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation | Q33784839 | ||
Roles of Asp54 and Asp213 in Ca2+ utilization by soluble human CD39/ecto-nucleotidase | Q34149723 | ||
Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis | Q34171790 | ||
Leukocyte-endothelial cell interactions in the inflammatory response | Q34633418 | ||
Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8. | Q34769242 | ||
P2 receptors in cardiovascular regulation and disease | Q36464824 | ||
CD39/NTPDase-1 activity and expression in normal leukocytes | Q36479951 | ||
Platelet-leukocyte interactions in inflammation and atherothrombosis | Q36752801 | ||
Platelets and endothelial cells | Q36752804 | ||
PECAM-1: a multi-functional molecule in inflammation and vascular biology | Q36943068 | ||
Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases | Q37307308 | ||
Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39. | Q37381379 | ||
Overexpression of CD39/nucleoside triphosphate diphosphohydrolase-1 decreases smooth muscle cell proliferation and prevents neointima formation after angioplasty. | Q41761170 | ||
Comparison of ICAM-1 and VCAM-1 expression in various human endothelial cell types and smooth muscle cells | Q42464591 | ||
Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans | Q44513178 | ||
Leukocyte count and leukocyte ecto-nucleotidase are major determinants of the effects of adenosine triphosphate and adenosine diphosphate on platelet aggregation in human blood | Q46596616 | ||
Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats | Q48370949 | ||
Reconstitution of CD39 in liposomes amplifies nucleoside triphosphate diphosphohydrolase activity and restores thromboregulatory properties | Q48450718 | ||
Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. | Q50324471 | ||
Photochemically induced endothelial injury in the mouse as a screening model for inhibitors of vascular intimal thickening. | Q50523399 | ||
P433 | issue | 2 | |
P304 | page(s) | 426-434 | |
P577 | publication date | 2009-12-18 | |
P1433 | published in | Thrombosis and Haemostasis | Q15724413 |
P1476 | title | Human solCD39 inhibits injury-induced development of neointimal hyperplasia | |
P478 | volume | 103 |
Q34376573 | A study of the imbalance in B cell-expressed nucleoside triphosphate diphosphohydrolase 1-induced ADP degradation in graft injury during acute antibody-mediated rejection |
Q58102990 | ENPP1-Fc prevents neointima formation in generalized arterial calcification of infancy through the generation of AMP |
Q35779631 | In vitro Study of a Novel Stent Coating Using Modified CD39 Messenger RNA to Potentially Reduce Stent Angioplasty-Associated Complications |
Q89029585 | Mechanism of Nucleoside Triphosphate Diphosphohydrolase-1-Associated Imbalance in Adenosine Diphosphate Degradation, B-Cell Activation, and Related Injury During Acute Antibody-Mediated Rejection |
Q67406317 | Nucleotide ecto-enzyme metabolic pattern and spatial distribution in calcific aortic valve disease; its relation to pathological changes and clinical presentation. |
Q43102079 | Optimizing human apyrase to treat arterial thrombosis and limit reperfusion injury without increasing bleeding risk |
Q34667425 | Proteomic identification of biomarkers of vascular injury. |
Q47994855 | Recombinant soluble apyrase APT102 inhibits thrombosis and intimal hyperplasia in vein grafts without adversely affecting hemostasis or re-endothelialization |